Table 30.

Use of macrolides and relationship to mortality (Multivariate analysis adjusted according to clinical variables)

	Odds ratio (95% CI)	p value
Use of macrolides	0.64 (0.56–0.73)	< 0.001
Age	1.08 (1.07–1.09)	< 0.001
Smoking status
Never	–	1 (ref.)
Former	1.38 (1.19–1.59)	< 0.001
Current	1.62 (1.21–2.18)	0.001
Fever
No (< 37 °C)	–	1 (ref.)
Low-grade fever (37–37.9 °C)	0.97 (0.79–1.18)	0.76
Fever (> 38 °C)	0.87 (0.73–1.04)	0.12
Shortness of breath	1.31 (1.14–1.51)	< 0.001
Oxygen saturation > 90%	0.45 (0.39–0.51)	< 0.001
Tachypnea	1.95 (1.70–2.24)	< 0.001
C-reactive protein (mg/L)	1.01 (1.00–1.01)	< 0.001
Procalcitonin (ng/mL) > 0.15	4.83 (3.86–6.04)	< 0.001
Use of systemic corticosteroids	1.60 (1.39–1.84)	< 0.001
Use of tocilizumab	1.89 (1.49–2.39)	< 0.001